Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$4.07 -0.03 (-0.73%)
As of: Nov 11, 2026 · 9:35 AM EST

Tonix Pharmaceuticals Holding (TNXP) Return on Equity [ROE] (2012 - 2026)

Updated

Tonix Pharmaceuticals Holding (TNXP) posted Return on Equity [ROE] of -71.87% for Q2 2026, down 24.48 percentage points from -47.39% a year earlier and down 9.51 percentage points from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Return on Equity [ROE] (2012 - 2026) Analysis & Trends

For FY2025, Tonix Pharmaceuticals Holding's Return on Equity [ROE] came in at -63.24%, up 49.30 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +40.74 percentage points (FY2020 to FY2025).
  • In prior years, Tonix Pharmaceuticals Holding's Return on Equity [ROE] was -112.54% in FY2024 (-37.93 pp), -74.61% in FY2023 (-22.85 pp), -51.76% in FY2022 (+8.49 pp) and -60.25% in FY2021 (+43.73 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2025.
  • On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +32.97 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2025, with a gain of 194.49 percentage points; the weakest was Q3 2024, with a drop of 151.24 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -62.36% (Q1 2026), -51.54% (Q4 2025) and -49.38% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Tonix Pharmaceuticals Holding 78.52 Mn -653.62 Mn 15.98 Mn -86.45%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -86.45%
Jun 30, 2026 -71.24%
Mar 31, 2026 -61.96%
Dec 31, 2025 -51.14%
Sep 30, 2025 -48.91%
Jun 30, 2025 -46.85%
Mar 31, 2025 -82.24%
Dec 31, 2024 -128.42%
Sep 30, 2024 -243.87%
Jun 30, 2024 -204.95%
Mar 31, 2024 -98.29%
Dec 31, 2023 -103.07%
Sep 30, 2023 -92.63%
Jun 30, 2023 -79.78%
Mar 31, 2023 -62.70%
Dec 31, 2022 -50.55%
Sep 30, 2022 -47.28%
Jun 30, 2022 -44.76%
Mar 31, 2022 -45.96%
Dec 31, 2021 -43.85%
API Access

Tonix Pharmaceuticals Holding Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TNXP&period=max&api_key=YOUR_API_KEY